ALXN: Alexion Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 18,599.90
Enterprise Value ($M) 20,367.49
Book Value ($M) 9,706.60
Book Value / Share 43.29
Price / Book 1.99
NCAV ($M) -642.40
NCAV / Share -2.86
Price / NCAV -30.07

Profitability (mra)
Return on Invested Capital (ROIC) 0.01
Return on Assets (ROA) 0.01
Return on Equity (ROE) 0.01

Liquidity (mrq)
Quick Ratio 3.36
Current Ratio 3.87

Balance Sheet (mrq) ($M)
Current Assets 3,650.60
Assets 13,999.60
Liabilities 4,293.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 269.60
Net Income 77.60
Earnings Per Share Diluted 0.35
Earnings Per Share Basic 0.35

Cash Flow Statement (mra) ($M)
Cash From Operations 426.00
Cash from Investing 470.50
Cash from Financing 470.50

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2020-02-14 13G/A Price T Rowe Associates Inc /md/ 5.40 -31.50
2020-02-13 13G State Street Corp 5.13 3.03
2020-02-12 13G/A Vanguard Group Inc 7.57 3.34
2020-02-05 13G/A BlackRock Inc. 7.20 -1.96
2020-01-10 13G/A FMR LLC / Fidelity 6.69 -44.15
2017-02-13 13G/A Capital Research Global Investors 3.20 -52.36

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2020-02-04 10-K ALXN / Alexion Pharmaceuticals, Inc. 10-K – Annual Report – 10-K
2019-10-23 10-Q ALXN / Alexion Pharmaceuticals, Inc. 10-Q – Quarterly Report – 10-Q
2019-07-24 10-Q ALXN / Alexion Pharmaceuticals, Inc. 10-Q – Quarterly Report – 10-Q
2019-04-25 10-Q ALXN / Alexion Pharmaceuticals, Inc. 10-Q (Quarterly Report) 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2020-03-27 129,965 2,538,300 5.12
2020-03-26 99,960 2,851,200 3.51
2020-03-25 139,036 2,355,700 5.90
2020-03-24 191,069 2,920,100 6.54

(click for more detail)

(click for list of largest short owners)

Similar Companies
ALPN – Alpine Immune Sciences Inc ALT – Altimmune, Inc.
ALXA – Alexza Pharmaceuticals, Inc. AMAG – AMAG Pharmaceuticals, Inc.
AMBI – Ambit Biosciences Corp


Financial data and stock pages provided by
Fintel.io